Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis.

Lucca B PalavaniRaphael CamerotteBernardo Vieira NogueiraMárcio Yuri FerreiraLeonardo B OliveiraLucas Pari MitreWilson Coelho Nogueira de CastroGisele Lúcia Canto GomesLuis F Fabrini PaleareSávio BatistaFilipi Fim AndreãoRaphael BertaniAllan Dias Polverini

Published in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2024)

Results indicate that Belzutifan effectively stabilizes disease, reduces tumor progression, and achieves significant therapeutic responses, although side effects like anemia and fatigue were noted.

Keyphrases

systematic review
chronic kidney disease
poor prognosis
sleep quality
case control